Repository
How to publish
Resources
FAQs

Show simple item record

Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas

dc.contributor.authorGarcía Carracedo, Dario 
dc.contributor.authorVillaronga Torres, María de los Ángeles 
dc.contributor.authorÁlvarez Teijeiro, Saúl 
dc.contributor.authorSantamaría Ruiz de Azúa, Íñigo 
dc.contributor.authorAllonca Campa, Eva 
dc.contributor.authorSuárez Fernández, Laura 
dc.contributor.authorGonzález Meana, María Victoria 
dc.contributor.authorBalbín Felechosa, Milagros 
dc.contributor.authorAstudillo González, María Aurora 
dc.contributor.authorMartínez Camblor, Pablo 
dc.contributor.authorRodrigo Tapia, Juan Pablo 
dc.contributor.authorGarcía Pedrero, Juana María 
dc.date.accessioned2017-02-01T07:40:06Z
dc.date.available2017-02-01T07:40:06Z
dc.date.issued2016
dc.identifier.citationOncotarget, 7(20), p. 29780-29793 (2016); doi:10.18632/oncotarget.8957
dc.identifier.issn1949-2553
dc.identifier.urihttp://hdl.handle.net/10651/39672
dc.description.sponsorshipThis study was supported by grants from the Plan Nacional de I+D+I 2008-2011 Instituto de Salud Carlos III (PI11/00929 to JPR) and Plan Nacional de I+D+I 2013-2016 ISCIII (CP13/00013 and PI13/00259 to JMGP),RD12/0036/0015 of Red Temática de Investigación Cooperativa en Cáncer (RTICC), Spain, and the FEDER Funding Program from the European Union. M.A.V. is recipient of a fellowship from ISCIII (CD13/00157). Work in the laboratory of G.S. was funded by grant NIH R01CA109525
dc.description.statementofresponsibilityGarcía-Carracedo, D., Ángeles Villaronga, M., Álvarez-Teijeiro, S., Hermida-Prado, F., Santamaría, I., Allonca, E., Suárez-Fernández, L., Victoria Gonzalez, M., Milagros Balbín, M., Astudillo, A., Martínez-Camblor, P., Su, G.H., Rodrigo, J.P., García-Pedrero, J.M.
dc.format.extentp. 29780-29793
dc.language.isoeng
dc.relation.ispartofOncotarget
dc.rightsCC Reconocimiento 3.0 Unported
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/
dc.sourceScopus
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84969848812&partnerID=40&md5=0cd4ff7d2291f240806ee925c05f198d
dc.titleImpact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas
dc.typejournal article
dc.identifier.doi10.18632/oncotarget.8957
dc.relation.projectIDInstituto de Salud Carlos III/PI11/00929
dc.relation.projectIDPI13/00259
dc.relation.projectIDCP13/00013
dc.relation.publisherversionhttp://dx.doi.org/10.18632/oncotarget.8957
dc.rights.accessRightsopen access


Files in this item

untranslated
Name:
Oncotarget.pdf
Size:
2.900Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

CC Reconocimiento 3.0 Unported
This item is protected with a Creative Commons License